ARUK 2019 | Perspectives: current and future treatment landscape for Alzheimer’s

Carol Routledge

Carol Routledge, PhD, Director of Research at Alzheimer’s Research UK (ARUK), Cambridge, UK, who has a background in neuropharmacology, discussed with us her perspective on current and future treatments and therapy research for Alzheimer’s. Speaking at the ARUK Conference 2019, held in Harrogate, UK, Dr Routledge goes on to discuss what can be done to impove drug development.

Share this video